glp-1 drugs semaglutide Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns The ABC's of GLP-1s: Benefits,

There 9 types of antidiabetic drugs, of which GLP-1RAs are the most popular, find the evolution of GLP-1RAs and their challenges and solutions,

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide, are widely used in the treatment of metabolic disorders, including type 2 diabetes (T2D) and obesity

(HKEX: 1672) has unveiled ASC35, a next-generation GLP-1/GIP dual peptide agonist designed for once-monthly subcutaneous dosing in obesity treatment.

Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials

Results show broad benefits with a reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions